Spironolactone use does not increase the risk of female breast cancer recurrence: A retrospective analysis.

Authors

Chapman Wei, George Washington University
Patawut Bovonratwet
Alex Gu, George Washington University
Gaby Moawad, George Washington University
Jonathan I. Silverberg, George Washington University
Adam J. Friedman, George Washington University

Document Type

Journal Article

Publication Date

5-21-2020

Journal

Journal of the American Academy of Dermatology

DOI

10.1016/j.jaad.2020.05.081

Comments

Online ahead of print

APA Citation

Wei, C., Bovonratwet, P., Gu, A., Moawad, G., Silverberg, J. I., & Friedman, A. J. (2020). Spironolactone use does not increase the risk of female breast cancer recurrence: A retrospective analysis.. Journal of the American Academy of Dermatology, (). http://dx.doi.org/10.1016/j.jaad.2020.05.081

Peer Reviewed

1